
Peres Jepchirchir, the renowned Olympic and World Championships marathon gold medalist, has been handed a provisional suspension by the Athletics Integrity Unit (AIU). The disciplinary action follows a positive drug test for the banned substance erythropoietin, commonly known as EPO. This development marks a significant blow to the career of one of the world's most successful long-distance runners, whose achievements have placed her at the pinnacle of international athletics.
The positive result stemmed from an out-of-competition sample collected prior to Jepchirchir's most recent competitive outing. Specifically, the sample was taken in the lead-up to her victory at the Sydney Marathon, which was held on 30 August 2026. The AIU’s findings indicate that the banned performance-enhancing drug was present in her system before she crossed the finish line as the winner in the Australian event.
EPO is a synthetic hormone that stimulates the production of red blood cells, thereby increasing oxygen delivery to muscles and significantly enhancing aerobic endurance. Its use is strictly prohibited under World Athletics anti-doping regulations due to the unfair advantage it provides in endurance sports. As a provisional suspension, the current ruling bars Jepchirchir from participating in any sanctioned athletics competition or activity until a final decision is reached following a formal disciplinary hearing.
The suspension of such a high-profile athlete is expected to have far-reaching implications for the sport. Jepchirchir now faces the prospect of a multi-year ban and the potential stripping of her Sydney Marathon title if the anti-doping rule violation is confirmed. The AIU is expected to provide further updates regarding the adjudication process and any subsequent appeals as the case progresses through the established legal framework for international sports.
Live rates
Ghana gold price →